This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cohen, R. N. Articles by Hollenberg, A. N. Search for Related Content PubMed PubMed Citation Articles by Cohen, R. N. Articles by Hollenberg, A. N.

The Specificity of Interactions between Nuclear Hormone Receptors and Corepressors Is Mediated by Distinct Amino Acid Sequences within the Interacting Domains

Section of Endocrinology (R.N.C., F.E.W.) Department of Medicine University of Chicago Chicago, Illinois 60637
Thyroid Unit (S.B., B.K., A.N.H.) Division of Endocrinology and Division of Bone and Mineral Metabolism (M.C.) Beth Israel Deaconess Medical Center Boston, Massachusetts 02215

The thyroid hormone receptor (TR) and retinoic acid receptor (RAR) isoforms interact with the nuclear corepressors [NCoR (nuclear corepressor protein) and SMRT (silencing mediator for retinoid and thyroid hormone receptors)] in the absence of ligand to silence transcription. NCoR and SMRT contain C-terminal nuclear hormone receptor (NHR) interacting domains that each contain variations of the consensus sequence I/L-x-x-I/V-I (CoRNR box). We have previously demonstrated that TRß1 preferentially interacts with NCoR, whereas RAR prefers SMRT. Here, we demonstrate that this is due, in part, to the presence of a novel NCoR interacting domain, termed N3, upstream of the previously described domains. An analogous domain is not present in SMRT. This domain is specific for TR and interacts poorly with RAR. Our data suggest that the presence of two corepressor interacting domains are necessary for full interactions with nuclear receptors in cells. Interestingly, mutation of N3 alone specifically decreases binding of NCoR to TR in cells but does not decrease NCoR-RAR interactions. In addition, while the exact CoRNR box sequence of a SMRT interacting domain is critical for recruitment of SMRT by RAR, the CoRNR box sequences themselves do not explain the strong interaction of the N2 domain with TRß1. Additional regions distal to the CoRNR box sequence are needed for optimal binding. Thus, through sequence differences in known interacting domains and the presence of a newly identified interacting domain, NCoR is able to preferentially bind TRß1. These preferences are likely to be important in corepressor action in vivo.

This article has been cited by other articles:

				M. D. Rosen and M. L. Privalsky Thyroid Hormone Receptor Mutations Found in Renal Clear Cell Carcinomas Alter Corepressor Release and Reveal Helix 12 as Key Determinant of Corepressor Specificity Mol. Endocrinol., August 1, 2009; 23(8): 1183 - 1192. [Abstract] [Full Text] [PDF]

				J. Y. Kim, Y. L. Son, and Y. C. Lee Involvement of SMRT Corepressor in Transcriptional Repression by the Vitamin D Receptor Mol. Endocrinol., February 1, 2009; 23(2): 251 - 264. [Abstract] [Full Text] [PDF]

				I. Astapova, L. J. Lee, C. Morales, S. Tauber, M. Bilban, and A. N. Hollenberg The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo PNAS, December 9, 2008; 105(49): 19544 - 19549. [Abstract] [Full Text] [PDF]

				M. C. Hodgson, H. C. Shen, A. N. Hollenberg, and S. P. Balk Structural basis for nuclear receptor corepressor recruitment by antagonist-liganded androgen receptor Mol. Cancer Ther., October 1, 2008; 7(10): 3187 - 3194. [Abstract] [Full Text] [PDF]

				M. H. Liu, J. Li, P. Shen, B. Husna, E. S. Tai, and E. L. Yong A Natural Polymorphism in Peroxisome Proliferator-Activated Receptor-{alpha} Hinge Region Attenuates Transcription due to Defective Release of Nuclear Receptor Corepressor from Chromatin Mol. Endocrinol., May 1, 2008; 22(5): 1078 - 1092. [Abstract] [Full Text] [PDF]

				J. Y. Kim, O. G. Park, J. W. Lee, and Y. C. Lee One- plus Two-hybrid System, a Novel Yeast Genetic Selection for Specific Missense Mutations Disrupting Protein/Protein Interactions Mol. Cell. Proteomics, October 1, 2007; 6(10): 1727 - 1740. [Abstract] [Full Text] [PDF]

				B. A. Jonas, N. Varlakhanova, F. Hayakawa, M. Goodson, and M. L. Privalsky Response of SMRT (Silencing Mediator of Retinoic Acid and Thyroid Hormone Receptor) and N-CoR (Nuclear Receptor Corepressor) Corepressors to Mitogen-Activated Protein Kinase Kinase Kinase Cascades Is Determined by Alternative mRNA Splicing Mol. Endocrinol., August 1, 2007; 21(8): 1924 - 1939. [Abstract] [Full Text] [PDF]

				K. P. Madauss, E. T. Grygielko, S.-J. Deng, A. C. Sulpizio, T. B. Stanley, C. Wu, S. A. Short, S. K. Thompson, E. L. Stewart, N. J. Laping, et al. A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator Mol. Endocrinol., May 1, 2007; 21(5): 1066 - 1081. [Abstract] [Full Text] [PDF]

				K. Moriyama, T. Tagami, T. Usui, M. Naruse, T. Nambu, Y. Hataya, N. Kanamoto, Y.-s. Li, A. Yasoda, H. Arai, et al. Antithyroid Drugs Inhibit Thyroid Hormone Receptor-Mediated Transcription J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1066 - 1072. [Abstract] [Full Text] [PDF]

				S. Mani, H. Huang, S. Sundarababu, W. Liu, G. Kalpana, A. B. Smith, and S. B. Horwitz Activation of the Steroid and Xenobiotic Receptor (Human Pregnane X Receptor) by Nontaxane Microtubule-Stabilizing Agents Clin. Cancer Res., September 1, 2005; 11(17): 6359 - 6369. [Abstract] [Full Text] [PDF]

				M. Togashi, P. Nguyen, R. Fletterick, J. D. Baxter, and P. Webb Rearrangements in Thyroid Hormone Receptor Charge Clusters That Stabilize Bound 3,5',5-Triiodo-L-thyronine and Inhibit Homodimer Formation J. Biol. Chem., July 8, 2005; 280(27): 25665 - 25673. [Abstract] [Full Text] [PDF]

				T. Ishizuka and M. A. Lazar The Nuclear Receptor Corepressor Deacetylase Activating Domain Is Essential for Repression by Thyroid Hormone Receptor Mol. Endocrinol., June 1, 2005; 19(6): 1443 - 1451. [Abstract] [Full Text] [PDF]

				X. Meng, P. Webb, Y.-F. Yang, M. Shuen, A. F. Yousef, J. D. Baxter, J. S. Mymryk, and P. G. Walfish E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode PNAS, May 3, 2005; 102(18): 6267 - 6272. [Abstract] [Full Text] [PDF]

				C. Yu, K. Markan, K. A. Temple, D. Deplewski, M. J. Brady, and R. N. Cohen The Nuclear Receptor Corepressors NCoR and SMRT Decrease Peroxisome Proliferator-activated Receptor {gamma} Transcriptional Activity and Repress 3T3-L1 Adipogenesis J. Biol. Chem., April 8, 2005; 280(14): 13600 - 13605. [Abstract] [Full Text] [PDF]

				M. L. Goodson, B. A. Jonas, and M. L. Privalsky Alternative mRNA Splicing of SMRT Creates Functional Diversity by Generating Corepressor Isoforms with Different Affinities for Different Nuclear Receptors J. Biol. Chem., March 4, 2005; 280(9): 7493 - 7503. [Abstract] [Full Text] [PDF]

				M. C. Hodgson, I. Astapova, S. Cheng, L. J. Lee, M. C. Verhoeven, E. Choi, S. P. Balk, and A. N. Hollenberg The Androgen Receptor Recruits Nuclear Receptor CoRepressor (N-CoR) in the Presence of Mifepristone via Its N and C Termini Revealing a Novel Molecular Mechanism for Androgen Receptor Antagonists J. Biol. Chem., February 25, 2005; 280(8): 6511 - 6519. [Abstract] [Full Text] [PDF]

				D. Masiello, S.-Y. Chen, Y. Xu, M. C. Verhoeven, E. Choi, A. N. Hollenberg, and S. P. Balk Recruitment of {beta}-Catenin by Wild-Type or Mutant Androgen Receptors Correlates with Ligand-Stimulated Growth of Prostate Cancer Cells Mol. Endocrinol., October 1, 2004; 18(10): 2388 - 2401. [Abstract] [Full Text] [PDF]

				M. Malartre, S. Short, and C. Sharpe Alternative splicing generates multiple SMRT transcripts encoding conserved repressor domains linked to variable transcription factor interaction domains Nucleic Acids Res., September 1, 2004; 32(15): 4676 - 4686. [Abstract] [Full Text] [PDF]

				W. Miyazaki, T. Iwasaki, A. Takeshita, Y. Kuroda, and N. Koibuchi Polychlorinated Biphenyls Suppress Thyroid Hormone Receptor-mediated Transcription through a Novel Mechanism J. Biol. Chem., April 30, 2004; 279(18): 18195 - 18202. [Abstract] [Full Text] [PDF]

				L. Pascual-Le Tallec, O. Kirsh, M.-C. Lecomte, S. Viengchareun, M.-C. Zennaro, A. Dejean, and M. Lombes Protein Inhibitor of Activated Signal Transducer and Activator of Transcription 1 Interacts with the N-Terminal Domain of Mineralocorticoid Receptor and Represses Its Transcriptional Activity: Implication of Small Ubiquitin-Related Modifier 1 Modification Mol. Endocrinol., December 1, 2003; 17(12): 2529 - 2542. [Abstract] [Full Text] [PDF]

				S. Benko, J. D. Love, M. Beladi, J. W. R. Schwabe, and L. Nagy Molecular Determinants of the Balance between Co-repressor and Co-activator Recruitment to the Retinoic Acid Receptor J. Biol. Chem., October 31, 2003; 278(44): 43797 - 43806. [Abstract] [Full Text] [PDF]

				R. N. Cohen, L. E. Cohen, D. Botero, C. Yu, A. Sagar, M. Jurkiewicz, and S. Radovick Enhanced Repression by HESX1 as a Cause of Hypopituitarism and Septooptic Dysplasia J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4832 - 4839. [Abstract] [Full Text] [PDF]

				X. Hu, S. Li, J. Wu, C. Xia, and D. S. Lala Liver X Receptors Interact with Corepressors to Regulate Gene Expression Mol. Endocrinol., June 1, 2003; 17(6): 1019 - 1026. [Abstract] [Full Text] [PDF]

				F. Liang, P. Webb, A. Marimuthu, S. Zhang, and D. G. Gardner Triiodothyronine Increases Brain Natriuretic Peptide (BNP) Gene Transcription and Amplifies Endothelin-dependent BNP Gene Transcription and Hypertrophy in Neonatal Rat Ventricular Myocytes J. Biol. Chem., April 18, 2003; 278(17): 15073 - 15083. [Abstract] [Full Text] [PDF]

				H. Akiyama, N. Fujisawa, Y. Tashiro, N. Takanabe, A. Sugiyama, and F. Tashiro The Role of Transcriptional Corepressor Nif3l1 in Early Stage of Neural Differentiation via Cooperation with Trip15/CSN2 J. Biol. Chem., March 14, 2003; 278(12): 10752 - 10762. [Abstract] [Full Text] [PDF]

				A. Makowski, S. Brzostek, R. N. Cohen, and A. N. Hollenberg Determination of Nuclear Receptor Corepressor Interactions with the Thyroid Hormone Receptor Mol. Endocrinol., February 1, 2003; 17(2): 273 - 286. [Abstract] [Full Text] [PDF]

				N. Shibusawa, A. N. Hollenberg, and F. E. Wondisford Thyroid Hormone Receptor DNA Binding Is Required for Both Positive and Negative Gene Regulation J. Biol. Chem., January 3, 2003; 278(2): 732 - 738. [Abstract] [Full Text] [PDF]

				N. Vasudevan, S. Ogawa, and D. Pfaff Estrogen and Thyroid Hormone Receptor Interactions: Physiological Flexibility by Molecular Specificity Physiol Rev, October 1, 2002; 82(4): 923 - 944. [Abstract] [Full Text] [PDF]

				A. Takeshita, M. Taguchi, N. Koibuchi, and Y. Ozawa Putative Role of the Orphan Nuclear Receptor SXR (Steroid and Xenobiotic Receptor) in the Mechanism of CYP3A4 Inhibition by Xenobiotics J. Biol. Chem., August 30, 2002; 277(36): 32453 - 32458. [Abstract] [Full Text] [PDF]

				M. Schulz, M. Eggert, A. Baniahmad, A. Dostert, T. Heinzel, and R. Renkawitz RU486-induced Glucocorticoid Receptor Agonism Is Controlled by the Receptor N Terminus and by Corepressor Binding J. Biol. Chem., July 12, 2002; 277(29): 26238 - 26243. [Abstract] [Full Text] [PDF]

				S. Deltour, S. Pinte, C. Guerardel, B. Wasylyk, and D. Leprince The Human Candidate Tumor Suppressor Gene HIC1 Recruits CtBP through a Degenerate GLDLSKK Motif Mol. Cell. Biol., July 1, 2002; 22(13): 4890 - 4901. [Abstract] [Full Text] [PDF]

				S. Cheng, S. Brzostek, S. R. Lee, A. N. Hollenberg, and S. P. Balk Inhibition of the Dihydrotestosterone-Activated Androgen Receptor by Nuclear Receptor Corepressor Mol. Endocrinol., July 1, 2002; 16(7): 1492 - 1501. [Abstract] [Full Text] [PDF]

				K. Jepsen and M. G. Rosenfeld Biological roles and mechanistic actions of co-repressor complexes J. Cell Sci., February 15, 2002; 115(4): 689 - 698. [Abstract] [Full Text] [PDF]